Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECAM: Efficacy and Safety of Chiglitazar Added to Metformin in Type 2 Diabetes
NCT04807348Phase 3Completed
- Sponsor
- Akeso, Inc.
- Start
- Jul 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chiglitazar in type 2 diabetes mellitus (T2DM), sponsored by Akeso, Inc.. Started Jul 2021; status: completed.
02
Drugs
chiglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04807348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04807348.